Publication
Title
Mandibular advancement device treatment efficacy is associated with polysomnographic endotypes
Author
Abstract
Rationale: Mandibular advancement device (MAD) treatment efficacy varies among obstructive sleep apnea (OSA) patients. Objectives: The current study aims to explain underlying individual differences in efficacy using OSA endotypic traits calculated from baseline clinical polysomnography: collapsibility (airflow at normal ventilatory drive, Vpassive), loop gain (drive response to reduced airflow), arousal threshold (drive preceding arousal), compensation (increase in airflow as drive increases) and the ventilatory response to arousal (VRA, increase in drive explained by arousal). Based on previous research, we hypothesized that responders to MAD treatment have a lower loop gain and milder collapsibility. Methods: Thirty-six patients (apnea-hypopnea index [AHI] 23.5[IQR:19.7-29.8]/h) underwent baseline and 3-month follow-up full polysomnography, with MAD fixed at 75% of maximal protrusion. Traits were estimated using baseline polysomnography according to Sands et al. (AJRCCM 2018). Response was defined as AHI reduction ≥ 50%. Results: MAD treatment significantly reduced AHI (49.7%[23.9-63.6] of baseline, median[IQR]). Responders exhibited lower loop gain (mean[95%CI], 0.53[0.48-0.58] vs. 0.65[0.57-0.73]; p=0.020) at baseline compared to non-responders, a difference that persisted after adjustment for baseline AHI and BMI. Elevated loop gain remained associated with non-response after adjustment for collapsibility (OR: 3.03 [1.16 - 7.88] per 1 SD increase in loop gain [SD=0.15]; p=0.023). Conclusions: MAD non-responders exhibit greater ventilatory instability, expressed as higher loop gain. Assessment of the baseline degree of ventilatory instability using this approach may improve upfront MAD treatment patient selection. Clinical Trial Registration: The current study is a secondary analysis of the parent clinical trial NCT01532050 (Clinicaltrial.gov)
Language
English
Source (journal)
Annals of the American Thoracic Society. - New York, N.Y., 2013, currens
Proceedings of the American Thoracic Society. - New York, N.Y., 2004 - 2012
Publication
New York, N.Y. : American Thoracic Society , 2021
ISSN
2329-6933 [print]
2325-6621 [online]
DOI
10.1513/ANNALSATS.202003-220OC
Volume/pages
18 :3 (2021) , p. 511-518
Article Reference
AnnalsATS.202003-220OC
ISI
000625366600019
Pubmed ID
32946702
Medium
E-only publicatie
Full text (Publisher's DOI)
Full text (open access)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Project info
The development of a multifactorial model to predict the outcome of mandibular advancement device therapy for obstructive sleep apnea based on the patients' phenotype.
Innovative pathophysiological phenotyping of obstructive sleep apnea patients for individualized therapy selection.
Mobile and technological solutions for occupational drivers (MILESTONE).
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 22.02.2021
Last edited 02.10.2024
To cite this reference